UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $148M
- YoY, 2025
- +2.6%
- 5-year CAGR
- −2.0%
- 10-year CAGR
- −6.2%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $148M | +2.6% |
| 2024 | $144M | +268.3% |
| 2023 | $39M | −63.4% |
| 2022 | $107M | −22.9% |
| 2021 | $139M | −15.4% |
| 2020 | $164M | +260.8% |
| 2019 | $45M | — |
| 2018 | −$26M | — |
| 2017 | $74M | +507.4% |
| 2016 | $12M | −95.7% |
| 2015 | $280M | +47.4% |
| 2014 | $190M | −40.7% |
| 2013 | $321M | +965.2% |
| 2012 | $30M | — |
| 2011 | −$16M | — |
| 2010 | $114M | +12.8% |
| 2009 | $101M | +251.9% |
| 2008 | $29M | — |